Perspective Therapeutics (CATX) Construction in Progress (2011)
Perspective Therapeutics (CATX) posted Construction in Progress of $123613.0 for Q2 2011.
Perspective Therapeutics (CATX) Construction in Progress (2011) Analysis & Trends
Perspective Therapeutics has reported Construction in Progress for 1 years, with the latest figure at $123613.0 in Q2 2011.
- Quarterly Construction in Progress changed N/A year-over-year to $123613.0 in Q2 2011, while the trailing twelve-month figure through Jun 2011 was $123613.0 (changed N/A YoY) and the FY2011 annual result came in at $123613.0, changed N/A from the prior year.
- Construction in Progress steadied at $123613.0 in Q2 2011 per CATX's latest filing.
- Over five years, Construction in Progress peaked at $123613.0 in Q2 2011 and troughed at $123613.0 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 911.00 Mn |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | - |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 455.10 Mn |
| 10 | Perspective Therapeutics | 384.27 Mn | 384.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 123,613.00 |